Cas 515133-60-5,Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate

515133-60-5

Post Buying Request

Basic information

Product Name: Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate
Synonyms: Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate
CAS NO:515133-60-5
Molecular Formula:
Molecular Weight: 377.527
EINECS: N/A
Product Categories: N/A
Mol File: 515133-60-5.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate(CAS DataBase Reference)
NIST Chemistry Reference: Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate(515133-60-5)
EPA Substance Registry System: Isobutyl 3-[4-(diphenylmethylidene)piperidin-1-yl]propanoate(515133-60-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 515133-60-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

515133-60-5 Suppliers

Recommended suppliersmore

515133-60-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 515133-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,5,1,3 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 515133-60:
(8*5)+(7*1)+(6*5)+(5*1)+(4*3)+(3*3)+(2*6)+(1*0)=115
115 % 10 = 5
So 515133-60-5 is a valid CAS Registry Number.

515133-60-5Upstream product

515133-60-5Downstream Products

515133-60-5Relevant articles and documents

Treatment of CNS disorders using CNS target modulators

-

, (2008/06/13)

The invention is directed to compositions and methods useful for treating Central Nervous System (CNS) disorders. Furthermore, the invention provides compositions and methods of treating sleep disorders. More specifically, the invention is directed to the compositions and use of derivatized, histamine antagonists for the treatment of sleep disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 515133-60-5